CVAC Description — CureVac NV

CureVac is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company developing medicines based on messenger ribonucleic acid (mRNA). Co.'s product portfolio includes clinical and preclinical candidates in prophylactic vaccines, oncology and molecular therapy. In prophylactic vaccines, Co. is developing its mRNA vaccine candidate, CV2CoV against coronavirus (SARS-CoV-2) in collaboration with GlaxoSmithKline Biologicals SA. CV2CoV is a representative of its COVID-19 vaccine program. The vaccine candidate is a non-chemically modified mRNA, encoding the prefusion stabilized full-length spike protein of the SARS-CoV-2 virus, and formulated within Lipid Nanoparticles.

Company Name: 
CureVac NV
Drugs & Pharmaceuticals
Number of ETFs Holding CVAC: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   CVAC Weight   CVAC Amount 
 IDNA   1.01%   $1,416,927         
 KOMP   0.09%   $1,410,739         
 SPDW   0.00%   $214,241         
 VT   0.00%   $147,684         
 BIB   0.10%   $97,566         
 ESGV   0.00%   $66,012         
 IBBQ   0.14%   $17,790         
Quotes delayed 20 minutes

Email EnvelopeFree CVAC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.00 out of 4)
31st percentile
(ranked lower than approx. 69% of all stocks covered)
Based on data provided by Zacks Investment Research via

ETFs Holding CVAC | CureVac NV | ETF Channel |

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.